Compare McKesson Corporation (MCK) vs Sibanye Stillwater Ltd (SBSW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs Sibanye Stillwater Ltd — how do they compare? McKesson Corporation trades at $829.95 (market cap $97.35B), while Sibanye Stillwater Ltd trades at $8.31 (market cap $5.66B). The key difference: McKesson Corporation is far larger — about 17.2× Sibanye Stillwater Ltd's market cap, and Sibanye Stillwater Ltd pays the higher dividend (3.89%). Which is the better fit depends on your goals.
| MCK | SBSW | |
|---|---|---|
Market Cap | $97.35B | $5.66B |
Sector | Health | Basic Materials |
52-Week High | $995.69 | $21.12 |
52-Week Low | $659.01 | $7.27 |
Enterprise Value | $101.98B | $7.28B |
Dividend Yield | 0.39% | 3.89% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $831.60, down 1.16% on the day, with a bullish technical signal and positive earnings momentum after beating estimates for three consecutive quarters. The stock shows strong analyst support with an 80% buy rating and a consensus price target of $932.83, implying potential upside. Revenue growth is robust, reaching $359.05 billion in 2025, though net margins remain thin at 1.18%. Cash flow from operations improved to $6.09 billion in 2025, supporting financial stability.
The outlook for MCK is positive, driven by earnings beats, analyst optimism, and solid cash generation. Key opportunities include growth in specialty pharma and oncology services. Risks involve policy uncertainties, competitive pressures, and execution challenges. The stock's current price near key support at $829 suggests a critical level for near-term direction.
Sibanye Stillwater (SBSW) trades at $8.02, up 0.25% on the day, with technical indicators showing a bearish trend. The company reported a net loss of $7.30 billion in 2024, though revenue remained stable at $112.13 billion. Recent news highlights management's focus on debt reduction and operational improvements, with Seeking Alpha noting a 5x YoY EBITDA surge driven by strong PGM and gold prices as of July 3, 2026.
The stock presents a high-risk opportunity with a consensus price target of $14.25, implying significant upside, but faces headwinds from negative profitability metrics and volatile commodity prices. Investors should weigh the potential turnaround against ongoing operational challenges and macroeconomic risks in the mining sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About Sibanye Stillwater Ltd
Sibanye Stillwater Ltd is a South Africa-focused mining company. The Group currently owns and operates five underground and surface gold operations in South Africa: the Cooke, DRDGOLD, Driefontein, and Kloof operations in the West Witwatersrand region, and the Beatrix Operation in the southern Free State province. In addition to mining, the company owns and manages extraction and processing facilities at its operations, where gold-bearing ore is treated and beneficiated to produce gold dore. The gold dore is further refined at Rand Refinery into gold bars with a purity of at least 99.5% and is then sold on international markets. Sibanye holds a 44% interest in Rand Refinery, global refiners of gold, and the largest in Africa. Rand Refinery markets gold to customers around the world.
Read more on SBSW →
